| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Net income | -53.9 | -45.8 |
| EPS (diluted, $ a share) | $-0.36 | $-0.48 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
10-Q filed with the SEC, NASDAQ: SLDB. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Solid Biosciences Inc.: key numbers
- Share price
- $6.48Close, Nov 16
- Market cap
- $723M
- Shares outstanding
- 111.61MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Biological Products, (No Diagnostic Substances)SIC 2836
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Solid Biosciences Inc.
All →Solid Biosciences CMO Gabriel Brooks Sells $24.6K of Stock
Gabriel Brooks, CMO, sold 4,374 shares of Solid Biosciences Inc. at $5.62 a share, worth $24.6K in total on Oct 19, 2026. Shares held after the trade: 97,241 (-4.3%).
- Value
- $24.6K
- Shares
- 4,374
- Price
- $5.62
- Role
- CMO
- Holding change
- -4.3%
- Trade date
- Oct 19, 2026